Antiviral Activity of Oligonucleotides Targeting the SARS-CoV-2 Genomic RNA Stem-Loop Sequences within the 3′-End of the ORF1b

Increased evidence shows vaccines against severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) exhibited no long-term efficacy and limited worldwide availability, while existing antivirals and treatment options have only limited efficacy. In this study, the main objective was the development...

Descripción completa

Detalles Bibliográficos
Autores principales: Stincarelli, Maria Alfreda, Rocca, Arianna, Antonelli, Alberto, Rossolini, Gian Maria, Giannecchini, Simone
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2022
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9696570/
https://www.ncbi.nlm.nih.gov/pubmed/36365037
http://dx.doi.org/10.3390/pathogens11111286

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9696570/
https://www.ncbi.nlm.nih.gov/pubmed/36365037
http://dx.doi.org/10.3390/pathogens11111286

Ejemplares similares